Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery.
about
Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis.Local staging of sigmoid colon cancer using MRI.ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.
P2860
Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@en
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@nl
type
label
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@en
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@nl
prefLabel
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@en
Mid-term oncologic outcome of ...... vant chemotherapy and surgery.
@nl
P2093
P2860
P1476
Mid-term oncologic outcome of ...... uvant chemotherapy and surgery
@en
P2093
A Chopitea
I González
J Baixauli
J L Hernández-Lizoain
J Rodriguez
P Martínez
P2860
P2888
P304
P356
10.1007/S12094-016-1539-4
P577
2016-08-05T00:00:00Z